From Medscape Diabetes & Endocrinology

American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting

September 20 - 23, 2019; Orlando, FL

September 20 - 23, 2019 Orlando, FL

ASBMR 2019 No Bone Benefits Seen With High-Dose Vitamin D in Healthy Cohort Long-term use of daily high-dose vitamin D shows no improvements in bone health or reductions in falls versus placebo, in new analyses of the VITAL trial in generally healthy middle-aged individuals.
Medscape Medical News, September 30, 2019
ASBMR 2019 Red Blood Cell Width Predicts Hip Fracture Risk Red blood cell width, routinely available in full blood counts, is associated with likelihood of hip fracture and could offer a good way to identify high risk patients at no cost, say researchers.
Medscape Medical News, September 26, 2019
ASBMR 2019 Calcium in Food or Supplement Is Safe in Postmenopausal Women Healthy postmenopausal women randomized to dietary or supplemental calcium show no negative effects in key vascular measures.
Medscape Medical News, September 24, 2019

ASBMR Urges Bone Treatment for All Seniors With Major Fractures Only a minority of older patients who have a hip or spine fracture receive secondary prevention with osteoporosis therapy. Bone specialists issued a set of recommendations to try to improve this.
Medscape Medical News, Oct 01, 2018
Study Finds BMD Can Stand in for Fractures. Will the FDA Agree? A meta-analysis of osteoporosis drugs showed that change in DXA BMD was a surrogate for fracture risk. If accepted by the FDA, it would 'really open up the field to a lot of new treatments.'
Medscape Medical News, Oct 03, 2018
Beyond 2 Years, Bisphosphonate Holiday Ups Broken Hip Risk Ceasing oral bisphosphonates for more than 2 to 3 years is probably undesirable for many patients, researchers report. The study also shows that it is important to continue to monitor bone density
Medscape Medical News, Oct 01, 2018
Are Osteoporosis Drugs Linked With Survival? Debate Casts Doubt The mortality benefit of osteoporosis drugs is "probably around 10%," claims one expert. However, strong evidence to support prescribing these drugs for this reason "is just not there," says another.
Medscape Medical News, October 11, 2018
Zoledronate Reduces Fractures in Older Women With Osteopenia Clinicians can tell women in their 70s with osteopenia who are very concerned about osteoporotic fractures that this drug 'won't make you bulletproof, but it will reduce [fracture risk] by about a third.
Medscape Medical News, Oct 11, 2018

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage